Q1 2025 Management View CEO Jeffrey Mezger announced a new CFO appointment, with Rob Dillard set to join as EVP and CFO, highlighting his extensive operational and financial background. The company ...
Accenture demonstrated solid revenue growth in its recent earnings, outpacing estimates, but faced marginal EPS pressures.
HC Wainwright issued their Q2 2025 earnings estimates for Capricor Therapeutics in a report issued on Thursday, March 20th.
Reports Q2 revenue $8.05B, consensus $7.9B. “Micron (MU) delivered fiscal Q2 EPS above guidance and data center revenue tripled from a year ...
Micron Technology's AI-driven demand in DRAM and HBM fuels strong growth, with undervaluation offering upside potential.